"10.1371_journal.pone.0029231","plos one","2012-01-05T00:00:00Z","Spyros A Kalams; Scott Parker; Xia Jin; Marnie Elizaga; Barbara Metch; Maggie Wang; John Hural; Michael Lubeck; John Eldridge; Massimo Cardinali; William A Blattner; Magda Sobieszczyk; Vinai Suriyanon; Artur Kalichman; David B Weiner; Lindsey R Baden; the NIAID HIV Vaccine Trials Network","Division of Infectious Diseases, Department of Medicine, Department of Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of Ameica; Division of Infectious Disease, Department of Medicine, University of Alabama Medical Center, Birmingham, Alabama, United States of America; Department of Medicine, University of Rochester Medical Center, Rochester, New York, United States of America; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America; Pfizer, Inc. Pearl River, New York, United States of America; Profectus BioSciences, Inc. Tarrytown, New York, United States of America; Institute of Human Virology, University of Maryland at Baltimore, Baltimore, Maryland, United States of America; Columbia University School of Medicine, New York, New York, United States of America; Chiang Mai Ram Hospital, Chiang Mai, Thailand; Centro de Referencia e Treinamento em DST/AIDS, Sao Paulo, Brazil; Department of Pathology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America; Division of Infectious Disease, Brigham and Womens Hospital, Boston, Massachusetts, United States of America","Conceived and designed the experiments: SK SP XJ ME LB. Performed the experiments: JH. Analyzed the data: SK ME BM MW JH LB. Contributed reagents/materials/analysis tools: ML JE DW. Wrote the paper: SK XJ ME BM LB. Site PIs: SK XJ SP WB MS VS AK. Safety monitoring: ME MC.","ML was an employee of Wyeth (now Pfizer, Inc.) during the course of the trial. JE was formerly employed by Wyeth (now Pfizer), is currently employed by Profectus BioSciences (PB), and holds stock or options in both companies.  PB has licensed a portfolio of issued and pending patents from Pfizer in the area of DNA vaccines, is actively developing DNA IL-12 as a product, and support for that development has been provided by the Natinal Institutes of Health under contract HHSN 80062C awarded to JE. The remaining authors have declared that no competing interests exist. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","01","Spyros A Kalams","SAK",17,FALSE,5,1,6,5,TRUE,TRUE,TRUE,1,"17",TRUE
